Novel Agents and Combinations in Hodgkin Lymphoma

0 Mga view
administrator
administrator
07/09/23

Panelists discuss novel agents, such as HDAC inhibitors, being explored in clinical trials for patients with Hodgkin lymphoma.

For more from this discussion, visit http://www.onclive.com/peer-exchange/lymphoma

  • Kategorya

Magpakita ng higit pa

0 Mga komento Pagbukud-bukurin Ayon

Walang nakitang komento

Mga Komento sa Facebook

Susunod